Guided Therapeutics (GTHP) Receivables - Other (2011 - 2022)

Guided Therapeutics (GTHP) has 6 years of Receivables - Other data on file, last reported at $82984.0 in Q4 2022.

• For the quarter ending Q4 2022, Receivables - Other changed N/A year-over-year to $82984.0; the trailing twelve-month figure through Dec 2022 stood at $82984.0 (changed N/A YoY), and the FY2022 full-year result was $82984.0, changed N/A from the prior year.
• Receivables - Other grew to $82984.0 in Q4 2022, from $43057.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $350.0 million in Q2 2021 to a low of $24785.0 in Q2 2022.
• A 5-year average of $39.5 million and a median of $130000.0 in 2022 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other surged 3280.0% in 2021 and tumbled 99.99% in 2022, its largest moves.
• Tracing GTHP's Receivables - Other over 5 years: stood at $661000.0 in 2018, then fell by 3.93% to $635000.0 in 2019, then slumped by 84.25% to $100000.0 in 2020, then surged by 349900.0% to $350.0 million in 2021, then tumbled by 99.98% to $82984.0 in 2022.
• Business Quant data shows GTHP's Receivables - Other at $82984.0 in Q4 2022, $43057.0 in Q3 2022, and $24785.0 in Q2 2022.